Waters, University of Delaware announce bioprocessing innovation partnership

21 October 2021 | News

Plan 2022 opening of Immerse Delaware Lab

Image Credit: Waters

Image Credit: Waters

Waters Corporation and the University of Delaware announced a five-year research partnership to develop new analytical solutions for bioprocessing and biomanufacturing.


Key to this partnership is Immerse Delaware, an Innovation and Research Lab, set to open in early 2022 located at the University of Delaware Science, Technology and Advanced Research (STAR) campus. At Immerse Delaware, Waters will partner with students and faculty to identify and address the most significant challenges facing the biopharmaceutical industry.


Waters is partnering with the University of Delaware because of its leadership in chemical and biological manufacturing research as well its active support and proximity to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a collaborative effort amongst industry, academia, and regulators.


The Immerse Delaware Lab will feature a purpose-built research testbed, with a focus on leveraging LC-MS and adjacent technologies to support bioprocess engineers’ empirical data in the areas of process and informatics. Initial projects at Immerse Delaware will seek to gain a deeper understanding of novel schemes to quantify and ultimately minimise process-related impurities from uncontrolled glycosylation, which negatively impacts drug efficacy. These will be paired with informatics solutions to predict the evolution of biotherapeutic products.




× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account